15 hours ago
1
Inflection Point Ventures (IPV), an angel investment platform, has launched 'IPV International, a $110 million Category I Angel Fund registered under GIFT City’s IFSCA (International Financial Services Centres Authority) framework, the company said in a statement.
The first close of the new fund happened in April 2025. It made the first investment in Singapore-based deeptech company Cellivate Technologies, which is working on replacing fetal bovine serum with a patented, ethical, and scalable cell-based alternative using magnetic stimulation, targeting biotech, pharma, and beyond.
Commenting on the new fund launch, Vinay Bansal, founder & CEO, IPV, said, "After establishing a strong presence in the Indian startup ecosystem, IPV is now extending its offerings through IPV International. Given the evolving global startup landscape and the rising appetite for international exposure, launching an international fund allows us to seamlessly participate in cross-border investment opportunities."
Also Read: Guwahati-based startup Littlebox raises over $2 million seed funding
"This strategic move enables us to consider high-potential foreign startups alongside domestic opportunities. By leveraging the global access provided by the GIFT City platform, we’re now well-positioned to invest in innovative ventures across international markets, enhancing both portfolio diversification and investor value," said Ankur Mittal, co-founder, IPV.
Mitesh Shah, co-founder, IPV commented, "We've backed unicorns, soonicorns, and high-growth startups that are driving meaningful change across the country. With a proven track record including 50 successful exits from a portfolio of over 220 startups, IPV is now set to leverage this experience and scale its platform to reach both national and international investors through IPV International. Combined with the tax efficiency and regulatory clarity offered by the GIFT City framework, the fund is well-positioned to attract a global investor base, including both domestic and international participants."
IPV is an angel investing platform with over 24,000 CXOs, HNIs, and professionals investing together in startups. The firm supports new-age entrepreneurs. IT has launched a $50 Mn CAT 2 VC fund, Physis Capital, to invest in Pre-Series A to Series B growth-stage startups. The fund has already deployed capital in six startups so far, with a few deals in advanced stages of the pipeline.
Also Read: Edtech startup Arivihan gets $4.17 million funding in pre-Series A round
English (US) ·